Look Under The Hood: JHMM Has 24% Upside
ETF Analysis: The John Hancock Multifactor Mid Cap ETF (JHMM) has an implied analyst target price of $70.42 per unit, indicating a potential upside of 23.56% from its current trading price of $56.99.
Underlying Holdings Performance: Notable underlying holdings like Viking Therapeutics Inc, PACS Group Inc, and Civitas Resources Inc show significant upside potential based on analyst targets, with expected increases ranging from 95.32% to 222.87%.
Trade with 70% Backtested Accuracy
Analyst Views on JHMM
About the author
Unexpected 12-Month Forecast for JHMM by Analyst
ETF Analysis: The John Hancock Multifactor Mid Cap ETF (JHMM) has an implied analyst target price of $74.62, indicating a potential upside of 16.60% from its current trading price of $64.00.
Notable Holdings: Key underlying holdings with significant upside potential include Rambus Inc. (20.53% upside), Fabrinet (19.62% upside), and MKS Inc. (17.97% upside) based on their respective analyst target prices.
Market Sentiment: The disparity between current trading prices and analyst target prices raises questions about whether analysts are justified in their optimistic projections or if they are out of touch with recent market developments.
Investor Considerations: Investors are encouraged to conduct further research to assess the validity of analyst targets and the potential for price adjustments in light of changing company and industry conditions.
Breaking Down the Components: JHMM Aims for $73
ETF Analysis: The John Hancock Multifactor Mid Cap ETF (JHMM) has an implied analyst target price of $73.05, indicating a potential upside of 13.52% from its current trading price of $64.35.
Notable Holdings: Key underlying holdings contributing to this upside include National Fuel Gas Co. (NFG), Carnival Corp (CCL), and GlobalFoundries Inc (GFS), each with significant potential increases based on analyst target prices.
Analyst Target Justification: The article raises questions about whether analysts' target prices are justified or overly optimistic, suggesting that high targets could lead to downgrades if they are based on outdated information.
Investor Research: Investors are encouraged to conduct further research to assess the validity of analyst targets in light of recent company and industry developments.
Projected 12-Month Target for JHMM by Analysts
ETF Analysis: The John Hancock Multifactor Mid Cap ETF (JHMM) has an implied analyst target price of $72.46 per unit, indicating a potential upside of 15.46% from its current trading price of $62.76.
Notable Holdings: Key underlying holdings with significant upside potential include LINEAGE INC (22.47% upside), Advanced Drainage Systems Inc (19.13% upside), and Range Resources Corp (18.01% upside) based on their respective analyst target prices.
Analyst Target Justification: The article raises questions about whether analysts' target prices are justified or overly optimistic, suggesting that high targets could lead to future downgrades if they do not align with market realities.
Investor Research: Investors are encouraged to conduct further research to assess the validity of analyst targets in light of recent company and industry developments.
Projected Target Price for JHMM Analyst: $72
ETF Analysis: The John Hancock Multifactor Mid Cap ETF (JHMM) has an implied analyst target price of $72.06, indicating an 11.75% upside from its current trading price of $64.48.
Notable Holdings: Key underlying holdings with significant upside potential include Clearwater Analytics (73.02% upside), Paylocity (35.65% upside), and Corebridge Financial (24.36% upside) based on their respective analyst target prices.
Explore the Details: JHMM Shows Potential for 10% Growth
ETF Analysis: The John Hancock Multifactor Mid Cap ETF (JHMM) has an implied analyst target price of $71.72, indicating a potential upside of 10.40% from its current trading price of $64.96.
Notable Holdings: Key underlying holdings with significant upside potential include Axsome Therapeutics (AXSM) with a target price 47.94% higher, Mobileye Global (MBLY) with 31.12% upside, and Waystar Holding (WAY) with a target price 27.60% above its recent price.
How The Parts Add Up: JHMM Headed For $68
ETF Analysis: The John Hancock Multifactor Mid Cap ETF (JHMM) has an implied analyst target price of $67.64, indicating a potential upside of 14.10% from its current trading price of $59.28.
Stock Performance Insights: Notable underlying holdings such as Waystar Holding Corp, Knight-Swift Transportation Holdings Inc, and Middleby Corp show significant upside potential based on analysts' target prices, raising questions about the validity of these targets amidst market developments.
Unexpected 12-Month Forecast for JHMM by Analyst
ETF Analysis: The John Hancock Multifactor Mid Cap ETF (JHMM) has an implied analyst target price of $74.62, indicating a potential upside of 16.60% from its current trading price of $64.00.
Notable Holdings: Key underlying holdings with significant upside potential include Rambus Inc. (20.53% upside), Fabrinet (19.62% upside), and MKS Inc. (17.97% upside) based on their respective analyst target prices.
Market Sentiment: The disparity between current trading prices and analyst target prices raises questions about whether analysts are justified in their optimistic projections or if they are out of touch with recent market developments.
Investor Considerations: Investors are encouraged to conduct further research to assess the validity of analyst targets and the potential for price adjustments in light of changing company and industry conditions.
Breaking Down the Components: JHMM Aims for $73
ETF Analysis: The John Hancock Multifactor Mid Cap ETF (JHMM) has an implied analyst target price of $73.05, indicating a potential upside of 13.52% from its current trading price of $64.35.
Notable Holdings: Key underlying holdings contributing to this upside include National Fuel Gas Co. (NFG), Carnival Corp (CCL), and GlobalFoundries Inc (GFS), each with significant potential increases based on analyst target prices.
Analyst Target Justification: The article raises questions about whether analysts' target prices are justified or overly optimistic, suggesting that high targets could lead to downgrades if they are based on outdated information.
Investor Research: Investors are encouraged to conduct further research to assess the validity of analyst targets in light of recent company and industry developments.
Projected 12-Month Target for JHMM by Analysts
ETF Analysis: The John Hancock Multifactor Mid Cap ETF (JHMM) has an implied analyst target price of $72.46 per unit, indicating a potential upside of 15.46% from its current trading price of $62.76.
Notable Holdings: Key underlying holdings with significant upside potential include LINEAGE INC (22.47% upside), Advanced Drainage Systems Inc (19.13% upside), and Range Resources Corp (18.01% upside) based on their respective analyst target prices.
Analyst Target Justification: The article raises questions about whether analysts' target prices are justified or overly optimistic, suggesting that high targets could lead to future downgrades if they do not align with market realities.
Investor Research: Investors are encouraged to conduct further research to assess the validity of analyst targets in light of recent company and industry developments.
Projected Target Price for JHMM Analyst: $72
ETF Analysis: The John Hancock Multifactor Mid Cap ETF (JHMM) has an implied analyst target price of $72.06, indicating an 11.75% upside from its current trading price of $64.48.
Notable Holdings: Key underlying holdings with significant upside potential include Clearwater Analytics (73.02% upside), Paylocity (35.65% upside), and Corebridge Financial (24.36% upside) based on their respective analyst target prices.
Explore the Details: JHMM Shows Potential for 10% Growth
ETF Analysis: The John Hancock Multifactor Mid Cap ETF (JHMM) has an implied analyst target price of $71.72, indicating a potential upside of 10.40% from its current trading price of $64.96.
Notable Holdings: Key underlying holdings with significant upside potential include Axsome Therapeutics (AXSM) with a target price 47.94% higher, Mobileye Global (MBLY) with 31.12% upside, and Waystar Holding (WAY) with a target price 27.60% above its recent price.
How The Parts Add Up: JHMM Headed For $68
ETF Analysis: The John Hancock Multifactor Mid Cap ETF (JHMM) has an implied analyst target price of $67.64, indicating a potential upside of 14.10% from its current trading price of $59.28.
Stock Performance Insights: Notable underlying holdings such as Waystar Holding Corp, Knight-Swift Transportation Holdings Inc, and Middleby Corp show significant upside potential based on analysts' target prices, raising questions about the validity of these targets amidst market developments.
